SCHEMBL28066916

SCHEMBL28066916

Nc1nc(CC2CCCO2)ncc1CC1CCCO1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE8B O95263 6/20 0.39
TDP1 Q9NUW8 2/20 0.39
CYP3A4 P08684 2/20 0.39
MEN1 O00255 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
PKM P14618 1/20 0.39
ALOX15 P16050 1/20 0.39
ALDH1A1 P00352 2/20 0.38
USP2 O75604 1/20 0.38
HTT P42858 1/20 0.38
TNK2 Q07912 3/20 0.37
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
TSHR P16473 2/20 0.36
HIF1A Q16665 1/20 0.36
EPHX2 P34913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5591783 0.87 DHFR (0.45) TDP1CYP3A4MEN1CYP1A2CYP2C19
SCHEMBL30515644 0.87 DHFR (0.45) TDP1CYP3A4MEN1CYP1A2CYP2C19
SCHEMBL28066954 0.79 ADORA2A (0.39) PDE8BTDP1CYP3A4MEN1CYP1A2
SCHEMBL28066962 0.78 PDE8B (0.40) PDE8BTDP1CYP3A4MEN1CYP1A2
SCHEMBL3818983 0.75 TNK2 (0.40) TDP1CYP3A4MEN1CYP1A2CYP2C19
SCHEMBL30018228 0.72 TNK2 (0.42) TDP1CYP3A4MEN1CYP1A2CYP2C19
SCHEMBL30578309 0.71 POLB (0.46) TDP1CYP3A4MEN1CYP1A2CYP2C19
SCHEMBL30703742 0.70 QPCT (0.40) CYP3A4MEN1CYP1A2CYP2C19KMT2A
SCHEMBL28067027 0.70 PDE5A (0.47) MEN1KMT2AALDH1A1HTTADORA2A
SCHEMBL18109476 0.70 TNK2 (0.39) PDE8BTDP1CYP3A4MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105592850-A Inhibitors of ACK1/TNK2 tyrosine kinase H LEE MOFFITT CANCER CT &RES 2016-05-18 CN disclosed